Cynosure Expands Anti-Aging Aesthetic Solution With Introduction of Deep-Heating Wavelength for Affirm(TM) Workstation
February 02 2007 - 8:00AM
PR Newswire (US)
Device to Debut at American Academy of Dermatology Meeting
WESTFORD, Mass., Feb. 2 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ:CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
the addition of a new 1320 nm wavelength Nd:YAG laser for its
flagship Affirm(TM) workstation, one of the industry's most
comprehensive solutions for anti-aging applications, including skin
rejuvenation, treatments for wrinkles, discoloration and now tissue
tightening as a result of tissue coagulation. The new laser, which
is emitted through a proprietary disposable micro-lens array, will
be debuted at the American Academy of Dermatology's 2007 Annual
Meeting, which begins today in Washington, D.C. "We are excited
about the addition of the 1320 nm Nd:YAG laser for deep heating,
which completes our platform Affirm workstation for anti-aging
applications. The Affirm now incorporates three energy sources and
provides a versatile, flexible and cost-effective product for our
customers," said Cynosure President and CEO Michael Davin. "The
Affirm now can deliver a deep- heating component for tissue
tightening as a result of tissue coagulation, which complements the
current 1440 nm Nd:YAG laser for fractional micro-rejuvenation and
the Xenon Pulsed Light system for discoloration." The Affirm is the
only anti-aging system to couple Cynosure's proprietary Combined
Apex Pulse(TM) (CAP) and Mulitplex(TM) technology in one device.
The CAP technology is a unique, high-density disposable lens array
that redistributes laser energy in a combination of high and low
level heat to stimulate and remodel collagen production throughout
the treatment area. The system utilizes Cynosure's patent pending
Multiplex technology to enable the rapid sequential emission of two
wavelengths, 1320 nm and 1440 nm, from the same optical fiber with
a short delay between fixed pulses. According to the Millennium
Research Group, the skin rejuvenation market is expected to grow
annually by 18 percent, resulting in a $239 million industry by
2010, with approximately 4.4 million procedures performed per year
by 2010. Davin commented, "Prior to Affirm, physicians could only
target one condition and one skin layer during each treatment. With
Affirm they can now target multiple layers and treat fine to
moderate wrinkles, solar damage and skin laxity during a single
session that can last as little as 15 minutes. Previously, patients
often faced longer, more painful procedures that penetrated into
the dermal layers and could damage potentially healthy skin. With
Affirm and the integrated SmartCool(TM) system, the energy is
delivered to the optimal treatment depth, with less pain." "We've
found that treatments using the Affirm are often short enough that
patients can come in for treatment on their lunch breaks," said
Bruce E. Katz, M.D., Director, Juva Skin & Laser Center. "In
our experience, the Affirm system is effective in the treatment of
wrinkles and scars, and tightens the overlying tissue. We are
pleased not only with the results, but with the ease of treatment,
especially because there are no messy gels or topical anesthetics
needed." About Cynosure, Inc. Cynosure, Inc. develops and markets
aesthetic treatment systems that are used by physicians and other
practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular lesions, rejuvenate skin
through the treatment of shallow vascular and pigmented lesions,
laser lipolysis and temporarily reduce the appearance of cellulite.
Cynosure's products include a broad range of laser and other
light-based energy sources, including Alexandrite, pulsed dye,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information, contact
Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Any
statements in this press release about future expectations, plans
and prospects for Cynosure, Inc., including statements about the
future use and market acceptance of the Affirm system, the markets
in which Cynosure's products are sold, and other statements
containing the words "believes," "anticipates," "plans," "expects,"
"will," and similar expressions, constitute forward-looking
statements within the meaning of The Private Securities Litigation
Reform Act of 1995. Actual results may differ materially from those
indicated by such forward-looking statements as a result of various
important factors, including our history of operating losses, our
reliance on sole source suppliers, competition in the aesthetic
laser industry, economic, market, technological and other factors
discussed in Cynosure's Annual Report on Form 10-K filed with the
SEC. In addition, the forward-looking statements included in this
press release represent Cynosure's views as of the date of this
press release. Cynosure anticipates that subsequent events and
developments will cause its views to change. However, while
Cynosure may elect to update these forward-looking statements at
some point in the future, it specifically disclaims any obligation
to do so. These forward-looking statements should not be relied
upon as representing Cynosure's views as of any date subsequent to
the date of this press release. DATASOURCE: Cynosure, Inc. CONTACT:
Scott Solomon, Vice President of Sharon Merrill Associates, Inc.,
+1-617-542-5300, ; or Gretchen Bender of Greenough Communications,
Web site: http://www.cynosurelaser.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024